{"id":16297,"name":"Ennea Capital / Enea Tech and Biomedical Foundation","slug":"ennea-capital-enea-tech-and-biomedical-foundation","website":"https://www.eneatechbiomedical.it/","hqGeo":"Rome, Italy","stageFocus":["Seed","Pre-Seed"],"sectorTags":["EdTech","Healthcare"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Invests in Italian companies, including innovative startups and SMEs, to advance biomedical research, development and industrial conversion, and technology transfer. Its focus includes pharmaceuticals, vaccines, diagnostics, medical devices and telemedicine, as well as technology-transfer areas such as IT, green economy, agritech and deep tech.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"InnovHeart","companyUrl":null,"stage":"Not specified in the source","sector":"Medtech / cardiovascular devices","investmentYear":null,"description":"Develops transcatheter mitral valve replacement technology.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"BetaGlue Therapeutics","companyUrl":null,"stage":"Clinical-stage","sector":"Biotech / oncology","investmentYear":null,"description":"Develops an innovative radiotherapy platform called YntraDose for targeted treatment of unresectable solid tumours.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"WISE SpA","companyUrl":null,"stage":"Series D","sector":"Medtech / neurotechnology","investmentYear":null,"description":"Develops implantable neurotechnology and medical devices for neurological disease and chronic pain.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Recornea","companyUrl":null,"stage":"Seed","sector":"Medtech / ophthalmology","investmentYear":null,"description":"Develops technology for treating corneal diseases; the announcement says ENEA Tech e Biomedical led its seed round.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Tethis S.p.A.","companyUrl":null,"stage":"Not specified in the source","sector":"Diagnostics / biotech","investmentYear":null,"description":"Builds liquid biopsy and blood-based cancer detection technology.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Genenta Science","companyUrl":null,"stage":"Financing via mandatory convertible bond","sector":"Biotech / immuno-oncology","investmentYear":null,"description":"Develops Temferon, an immuno-oncology and cell-therapy program for cancer treatment.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Approxima Srl","companyUrl":null,"stage":"Not specified in the source","sector":"Medtech / cardiovascular devices","investmentYear":null,"description":"Develops a technology for treating tricuspid insufficiency.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"VST Srl","companyUrl":null,"stage":"Not specified in the source","sector":"Medtech / digital health","investmentYear":null,"description":"Works on a solution to monitor vital parameters.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Restorative Neurotechnologies Srl","companyUrl":null,"stage":"Not specified in the source","sector":"Medtech / neurorehabilitation","investmentYear":null,"description":"Spin-off focused on neurorehabilitation / neurotechnology solutions.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Valo Therapeutics Oy","companyUrl":null,"stage":"Capital increase / financing round","sector":"Biotech / oncology","investmentYear":null,"description":"Develops immunotherapy / oncology technologies.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":7,"partners":[{"id":53110,"name":"Cinzia Marchese","title":"President","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/cinzia-marchese-559a0a3b","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53112,"name":"Caterina Flick","title":"Head of Legal","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/caterinaflick","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53113,"name":"Carmela Notaro","title":"Manager Project","seniority":null,"focusTags":[],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53115,"name":"Unknown","title":"GP","seniority":null,"focusTags":["Biomedical innovation","Neurorehabilitation"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53111,"name":"Gianpiero Scirocco","title":"Human Resources Manager","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/gianpiero-scirocco-6ab04736","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53114,"name":"Giuseppina Mira","title":"Investment Manager","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/giuseppina-mira-4b770116","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":53109,"name":"Mario Poti","title":"Communications Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/mario-poti-b46b88261","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[],"contentUpdatedAt":null,"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"pre-seed","displayName":"Pre-Seed Investors","pageType":"stage"},{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-to-find-investors","title":"How to Find Investors: A VC's Playbook for Founders"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-28T01:15:15.456Z"}